CNSP — CNS Pharmaceuticals Share News
0.000.00%
Last trade - 00:00CNS Pharma rises on clearance for brain cancer drug trial in France
Brief: CNS Pharmaceuticals Reports Full Year 2021 Financial Results
Brief: CNS Pharmaceuticals Files For Offering Of 24.82 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
CNS Pharma rises on clearance for brain cancer drug trial in Switzerland
Brief: Cns Pharmaceuticals Receives Approval From Switzerland Ethics Committee For Its Potentially Pivotal Study Of Berubicin For The Treatment Of Glioblastoma Multiforme (Gbm)
Brief: CNS Doses First Group Of Patients With Berubicin In Study For Treatment Of Glioblastoma Multiforme (GBM)
CNS Pharma jumps as FDA grants 'fast track' designation to brain cancer drug
Brief: FDA Grants Fast Track Designation To CNS Pharmaceuticals For Berubicin For The Treatment Of Recurrent Glioblastoma Multiforme
Brief: Cns Pharmaceuticals Announces Inclusion In The Russell 2000® Index
Brief: CNS Pharmaceuticals Commences Patient Enrollment In Study Of Berubicin
Brief: CNS Pharmaceuticals Reports Q1 Results
CNS Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: CNS Pharmaceuticals Berubicin Trial Is On Schedule To Commence In March 2021
Brief: Wpd And Cns Pharmaceuticals Announce Positive Opinion Of Polish Central Ethics Committee For Wpd-201 Study And Central Irb Study Level Approval For Cns-201 Study
Brief: Cns Pharmaceuticals Inc Files For Mixed Shelf Of Upto $75 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Nikola, Pfizer, GameStop
CNS Pharma: Falls on pricing of $10 mln share offering
Brief: Cns Pharmaceuticals Announces Pricing Of $10 Mln Public Offering
Brief: Cns Pharmaceuticals Files For Offering Of Up To 3.46 Mln Shares Of Common Stock - SEC Filing